The BE OPTIMAL trial, a phase 3 randomized, double-blind, placebo-controlled study, evaluated the efficacy and safety of bimekizumab in biologic-naive adults with active psoriatic arthritis (PsA)....
Psoriatic arthritis (PsA) presents with diverse manifestations, including peripheral arthritis, enthesitis, tenosynovitis, dactylitis, axial involvement, and skin and nail psoriasis....
Axial Psoriatic Arthritis: A Need for Clear Definitions
Axial psoriatic arthritis (axPsA) is a distinct but underdefined manifestation of psoriatic arthritis, primarily affecting the spine and sacroiliac joints....
CASPAR Criteria Outperform Legacy Tools in Identifying Psoriatic Arthritis
Psoriatic arthritis (PsA) is a systemic, chronic inflammatory arthritis commonly associated with psoriasis and typically seronegative for rheumatoid factor....
Physician Associate and Nurse Practitioner Contributors to the Psoriatic Arthritis Center of Excellence
POCN’s Psoriatic Arthritis Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.
Robert Laugherty,
JD, MBA, PA-C
Physician Assistant and Director of Rheumatology, East Tennessee Medical Group
Nancy Eisenberger,
DNP, FNP-BC
Family Nurse Practitioner, Arthritis, Rheumatic & Bone Disease Associates
